Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Science Translational Medicine
|
October 6, 2021
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas
Pooja Panwalkar, Benita Tamrazi, Derek Dang, et al.
Science (New York, N.Y.)
|
April 21, 2018
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
Mariella G Filbin, Itay Tirosh, Volker Hovestadt, et al.
Nature Genetics
|
December 5, 2022
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location
Ilon Liu, Li Jiang, Erik R Samuelsson, et al.
Nature
|
February 7, 2022
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G Majzner, Sneha Ramakrishna, Kristen W Yeom, et al.
Cell Reports. Medicine
|
May 2, 2025
Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure
Jenna J LaBelle, Rebecca D Haase, Alexander Beck, et al.
Nature
|
July 26, 2019
Resolving medulloblastoma cellular architecture by single-cell genomics
Volker Hovestadt, Kyle S Smith, Laure Bihannic, et al.
Cell Reports
|
December 19, 2023
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma
Stephanie M Casillo, Taylor A Gatesman, Akanksha Chilukuri, et al.
Cancer Discovery
|
October 28, 2022
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma
Eshini Panditharatna, Joana G Marques, Tingjian Wang, et al.
Cell
|
July 23, 2019
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel, Julie Laffy, Mariella G Filbin, et al.
Cancer Cell
|
September 4, 2024
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Science Translational Medicine
|
October 6, 2021
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas
Pooja Panwalkar, Benita Tamrazi, Derek Dang, et al.
Science (New York, N.Y.)
|
April 21, 2018
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
Mariella G Filbin, Itay Tirosh, Volker Hovestadt, et al.
Nature Genetics
|
December 5, 2022
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location
Ilon Liu, Li Jiang, Erik R Samuelsson, et al.
Nature
|
February 7, 2022
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G Majzner, Sneha Ramakrishna, Kristen W Yeom, et al.
Cell Reports. Medicine
|
May 2, 2025
Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure
Jenna J LaBelle, Rebecca D Haase, Alexander Beck, et al.
Nature
|
July 26, 2019
Resolving medulloblastoma cellular architecture by single-cell genomics
Volker Hovestadt, Kyle S Smith, Laure Bihannic, et al.
Cell Reports
|
December 19, 2023
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma
Stephanie M Casillo, Taylor A Gatesman, Akanksha Chilukuri, et al.
Cancer Discovery
|
October 28, 2022
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma
Eshini Panditharatna, Joana G Marques, Tingjian Wang, et al.
Cell
|
July 23, 2019
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel, Julie Laffy, Mariella G Filbin, et al.
Cancer Cell
|
September 4, 2024
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke, et al.
Page
of 8